APA (7th ed.) Citation

Lu, X., Li, M., Li, Y., Yao, J., Zhang, L., Zeng, Z., . . . Li, F. (2024). Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder. Neuropharmacology, 258, N.PAG. https://doi.org/10.1016/j.neuropharm.2024.110089

Chicago Style (17th ed.) Citation

Lu, Xiao-Yu, et al. "Oral Edaravone Ameliorates Behavioral Deficits and Pathologies in a Valproic Acid-induced Rat Model of Autism Spectrum Disorder." Neuropharmacology 258 (2024): N.PAG. https://doi.org/10.1016/j.neuropharm.2024.110089.

MLA (9th ed.) Citation

Lu, Xiao-Yu, et al. "Oral Edaravone Ameliorates Behavioral Deficits and Pathologies in a Valproic Acid-induced Rat Model of Autism Spectrum Disorder." Neuropharmacology, vol. 258, 2024, p. N.PAG, https://doi.org/10.1016/j.neuropharm.2024.110089.